当「特发性」并非特发性:APHRODITE算法中基于影像学对无精子症的鉴别
APHRODITE标准将血清FSH和总睾酮正常、睾丸体积符合特征的无精子症男性归为第2组并考虑激素治疗,但正常FSH不能区分梗阻性与非梗阻性无精子症。梗阻性无精子症及因成熟阻滞导致的非梗阻性无精子症可能被误分入第2组而接受无效的促性腺激素治疗,本文建议早期影像学检查以识别隐匿性梗阻,但需前瞻性验证。
要点
- 正常FSH不能区分梗阻性与非梗阻性无精子症,两者均符合APHRODITE第2组特征。
- 被误分入第2组的梗阻性或成熟阻滞性无精子症患者可能接受无效的促性腺激素治疗。
- 作者建议早期使用治疗中心可及的影像学检查识别隐匿性梗阻,但需前瞻性验证。
核心结论
- APHRODITE标准第2组可能误纳入梗阻性无精子症或因成熟阻滞导致的非梗阻性无精子症,使其接受无效的促性腺激素治疗并延误确定性治疗。
- 作者建议早期影像学检查(使用治疗中心可及的任何模态)作为识别隐匿性梗阻、避免不必要激素治疗的潜在策略,但该策略需要前瞻性验证。
研究设计与样本
- 本文为评论文章,未报告系统检索范围或样本量。
主要发现
- 正常FSH浓度本身不能区分梗阻性与非梗阻性无精子症。
- 梗阻性无精子症具有与APHRODITE第2组定义相同的激素和睾丸体积特征。
- 因成熟阻滞导致的非梗阻性无精子症可表现相似,激素治疗也不太可能使其获益。
- 被误分入第2组的梗阻性无精子症或成熟阻滞性非梗阻性无精子症患者可能接受 prolonged、无效的促性腺激素治疗,同时确定性治疗被延迟。
关键数值与推荐
- APHRODITE第2组定义为血清FSH正常、总睾酮正常,并可考虑激素治疗。
临床怎么用
- 作者建议早期影像学检查(使用治疗中心可及的任何模态)以识别隐匿性梗阻并避免不必要的激素治疗,但该策略需要前瞻性验证。
局限性
- 作者提出的早期影像学策略需要前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The recently introduced APHRODITE criteria provide a structured framework for classifying and treating men with idiopathic male infertility, including azoospermic men in Group 2, who present with normal serum FSH and normal total testosterone concentrations and may be considered for hormonal therapy. However, a normal FSH concentration does not by itself distinguish obstructive from non-obstructive azoospermia, and obstructive azoospermia characteristically shares the same hormonal and testicular-volume profile that defines Group 2; non-obstructive azoospermia due to maturation arrest can present similarly, and hormonal therapy is unlikely to benefit these men either. Men with obstructive azoospermia or non-obstructive azoospermia due to maturation arrest who are misclassified in Group 2 may be exposed to prolonged, ineffective gonadotrophin therapy while definitive treatment is delayed. This commentary highlights this risk together with broader limitations of the APHRODITE criteria and proposes earlier imaging, using whichever modality is available at the treating centre, as a potential strategy to identify occult obstruction and avoid unnecessary hormonal therapy. This approach, however, requires prospective validation.
引用
- Barak S, Waldenberg N, Bar G, et al. When 'idiopathic' is not idiopathic: imaging-based differentiation of azoospermia in the APHRODITE algorithm. Reprod Biomed Online. 2026. PMID: 42998350. doi:10.1016/j.rbmo.2026.106017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。